Skip to content

Cancelled by the investigator. A Clinical Study on the Analgesic Efficacy of a Single Preoperative Dose of Anrekenfen in Patients Undergoing Ambulatory Laparoscopic Abdominal Surgery

A Clinical Study on the Analgesic Efficacy of a Single Preoperative Dose of Anrekenfen in Patients Undergoing Ambulatory Laparoscopic Abdominal Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112761
Enrollment
Unknown
Registered
2025-11-19
Start date
2025-12-01
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgesia

Interventions

Group F:Fifteen minutes before the operation began, 1 microgram per kilogram of Aricept was injected intravenously.
Group F:Fibroblastin injection of 50mg was administered 15 minutes before the surgery began.

Sponsors

Jining Medical College Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Age ranging from 18 years to 70 years old, either male or female. 2) Daytime inpatients undergoing laparoscopic surgery. 3) American Society of Anesthesiologists (ASA) classification levels I - IIA. 4) Able to understand the research process and the use of pain scales. 5) The subjects have no contraindications to the study drug. 6) Clearly understand and voluntarily participate in this study, and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Previous history of neurological disorders or chronic pain syndromes (defined as reflex sympathetic dystrophy or complex regional pain syndrome). 2) History of drug allergy to the study medication. 3) Severe respiratory diseases, cardiovascular and cerebrovascular diseases, mental or cognitive impairments that prevent patients from adhering to the study protocol. 4) History of drug or alcohol abuse, or chronic use of opioids (more than 3 months or a daily morphine equivalent of more than 5 milligrams per day for 1 month). 5) Pregnant women.

Design outcomes

Primary

MeasureTime frame
Postoperative pain assessment (NRS);

Secondary

MeasureTime frame
Recovery analgesia;

Countries

China

Contacts

Public ContactGuocao Wang

Jining Medical College Affiliated Hospital

377017647@qq.com+86 136 3943 5218

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026